Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study
Authors' conclusion
Despite advances in diabetes technology, hypoglycemia remains highly prevalent, impactful, and often poorly anticipated in pediatric type 1 diabetes.
Study context
- Population
- Children and adolescents with T1D attending routine pediatric diabetes visits at six centers in Belgium and Luxembourg
- Participants
- 232 children
- Outcome
- Hypoglycemia burden
Methodological detailsquestionnaire-based
- Questionnaire-based
Main finding
As reported in the abstract
- Hypoglycemia at least weekly, with moderate-to-high symptom severity
- 55.9%
- Cognitive and daily-life symptoms (impaired focus, fatigue, hunger, tremor), interfering with activities
- >60%
- Hypoglycemia identified as the dominant disease burden
- 39.7%
- Severe hypoglycemia (SH) reported
- 45.7%
- SH without clear cause
- 29.1%
Observational data: associations, not effects.
Further findings
SH management
- Recommended management, including glucagon use, inconsistently applied, even in recurrent SH
Adaptations after SH
- Insulin dose reductions
- 27.4%
- Increased sugar intake
- 21.1%
- Avoidance of physical activities
- 22.1%
Questionnaire discrimination vs Clarke score
- AUC
- 0.84
Original publication
Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study. Diabetes Metab. Published 10 June 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →